Multiple Assemblies exist for SMTL entry 4jwr
Co-crystal structure of MDM2 with inhibitor {(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl}acetic acid; X-RAY DIFFRACTION 2.35 Å

	SMTL ID 4jwr.1 Ligands {(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl}acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer
	SMTL ID 4jwr.2 Ligands {(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl}acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer
	SMTL ID 4jwr.3 Ligands {(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl}acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer